Literature DB >> 15939670

Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.

Daron Forman1, Chaorui Tian, John Iacomini.   

Abstract

Donor-specific transplantation tolerance can be established through the induction of molecular chimerism following reconstitution of lethally irradiated mice with autologous bone marrow expressing retrovirally transduced allogeneic MHC antigens. Here, we set out to define nonmyeloablative host conditioning regimens that would allow for establishment of molecular chimerism and the induction of donor-specific tolerance. Recipient mice received various doses of whole-body irradiation, together with costimulatory blockade using anti-CD154 monoclonal antibody prior to reconstitution with syngeneic bone marrow cells transduced with retroviruses carrying the gene encoding H-2K(b). Conditioning consisting of 3 Gy whole-body irradiation and treatment with anti-CD154 was sufficient to induce molecular chimerism resulting in stable multilineage expression of K(b) on hematopoietic cells. T cells from molecular chimeras were unable to lyse allogeneic targets expressing K(b) and contained substantially fewer K(b)-reactive IL-2- and IFN-gamma-producing CD4 T cells than controls receiving mock-transduced bone marrow. Induction of molecular chimerism using nonmyeloablative host conditioning allowed for permanent survival of K(b)-disparate allogeneic skin grafts. These data suggest that nonmyeloablative host conditioning can be used effectively to induce molecular chimerism resulting in transplantation tolerance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939670     DOI: 10.1016/j.ymthe.2005.03.035

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  6 in total

1.  Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen.

Authors:  Chaorui Tian; Xueli Yuan; Peter T Jindra; Jessamyn Bagley; Mohamed H Sayegh; John Iacomini
Journal:  Clin Immunol       Date:  2010-05-08       Impact factor: 3.969

Review 2.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

3.  Correction of murine hemophilia A by hematopoietic stem cell gene therapy.

Authors:  Morvarid Moayeri; Teresa S Hawley; Robert G Hawley
Journal:  Mol Ther       Date:  2005-10-12       Impact factor: 11.454

4.  Thymic gene transfer of myelin oligodendrocyte glycoprotein ameliorates the onset but not the progression of autoimmune demyelination.

Authors:  Christopher Siatskas; Natalie Seach; Guizhi Sun; Ashley Emerson-Webber; Aude Silvain; Ban-Hock Toh; Frank Alderuccio; B Thomas Bäckström; Richard L Boyd; Claude C Bernard
Journal:  Mol Ther       Date:  2012-02-21       Impact factor: 11.454

5.  Engraftment of retrovirally transduced Bet v 1-GFP expressing bone marrow cells leads to allergen-specific tolerance.

Authors:  Martina Gattringer; Ulrike Baranyi; Nina Pilat; Karin Hock; Christoph Klaus; Elisabeth Buchberger; Haley Ramsey; John Iacomini; Rudolf Valenta; Thomas Wekerle
Journal:  Immunobiology       Date:  2013-03-30       Impact factor: 3.144

6.  Tolerance to MHC class II disparate allografts through genetic modification of bone marrow.

Authors:  P T Jindra; S Tripathi; C Tian; J Iacomini; J Bagley
Journal:  Gene Ther       Date:  2012-07-26       Impact factor: 5.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.